Bromide

Bromide

SCHEMBL3248961

Br.PC(=C(c1ccccc1)c1ccccc1)c1ccccc1

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 3/20 0.39
CES2 O00748 2/20 0.39
TSHR P16473 2/20 0.39
DAO P14920 1/20 0.39
NAPRT Q6XQN6 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ESR1 P03372 2/20 0.38
F2 P00734 2/20 0.36
CYP3A4 P08684 2/20 0.36
MAPT P10636 2/20 0.36
BLM P54132 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
CA2 P00918 2/20 0.36
CA4 P22748 2/20 0.36
F10 P00742 1/20 0.36
F12 P00748 1/20 0.36
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
PKM P14618 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3476714 0.97 CES1 (0.41) CES1CES2TSHRDAONAPRT
Fluoride SCHEMBL9750381 0.94 CES1 (0.39) CES1CES2TSHRDAONAPRT
Bromide SCHEMBL28303463 0.78 CES1 (0.50) CES1CES2TSHRDAONAPRT
Bromide SCHEMBL26697305 0.78 CES1 (0.50) CES1CES2TSHRDAONAPRT
SCHEMBL67982 0.75 CES1 (0.53) CES1CES2TSHRDAONAPRT
Benzene SCHEMBL28326432 0.75 CES1 (0.53) CES1CES2TSHRDAONAPRT
SCHEMBL22361301 0.72 ESR1 (0.48) CES1CES2TSHRDAONAPRT
SCHEMBL26583197 0.72 CES2 (0.44) CES1CES2TSHRDAONAPRT
SCHEMBL9804411 0.72 CES2 (0.44) CES1CES2TSHRDAONAPRT
SCHEMBL9580190 0.72 CES1 (0.50) CES1CES2TSHRDAONAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087965-A1 COMPOSITION COMPRISING EPOXY RESIN WITH CONSTRAINED AROMATIC RINGS AND PHOTOBASE 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-04-30 WO disclosed
WO-2025200154-A1 TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-10-02 WO disclosed
US-12306577-B2 Electrophotographic member and electrophotographic image forming apparatus CANON KABUSHIKI KAISHA (JP) 2025-05-20 US disclosed
US-20240309240-A1 POLISHING COMPOSITION, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR SUBSTRATE FUJIMI INCORPORATED (JP) 2024-09-19 US disclosed
EP-4079800-B1 ELECTROPHOTOGRAPHIC MEMBER AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KK (JP) 2023-12-06 EP disclosed
CN-112007622-B Molecularly imprinted polymer beads for metal extraction and uses thereof 第六波创新公司 2023-01-10 CN disclosed
EP-3653663-B1 MOLDED ARTICLE AND ITS PRODUCTION METHOD TORAY INDUSTRIES (JP) 2022-12-28 EP disclosed
EP-4079800-A1 ELECTROPHOTOGRAPHIC MEMBER AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2022-10-26 EP disclosed
US-20220334506-A1 ELECTROPHOTOGRAPHIC MEMBER AND ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS CANON KABUSHIKI KAISHA (JP) 2022-10-20 US disclosed
WO-2022210246-A1 EPOXY RESIN COMPOSITION, CURED EPOXY RESIN PRODUCT, AND COATED FIBER-REINFORCED RESIN MOLDED ARTICLE OBTAINED USING SAME 東レ株式会社 2022-10-06 WO disclosed
US-8597579-B1 Molecularly imprinted polymer-denuder based sensors THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY (US) 2013-12-03 US disclosed
EP-2660196-A1 MANUFACTURING METHOD FOR FLUOROSULFONYLIMIDE AMMONIUM SALT Nippon Soda Co., Ltd. (JP) 2013-11-06 EP disclosed
WO-2013030193-A1 VERSATILE AND STEREOSPECIFIC SYNTHESIS OF GAMMA,DELTA -UNSATURATED AMINO ACIDS BY WITTIG REACTION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2013-03-07 WO disclosed
EP-2029601-B1 PYRIDOPYRIMIDINONE DERIVATIVES HOFFMANN LA ROCHE (CH) 2010-06-02 EP disclosed
US-7572801-B2 Pyridopyrimidinone derivatives which are HM74A agonists HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-7416703-B2 Polymer based lanthanide luminescent sensors for the detection of organophosphorus compounds THE JOHNS HOPKINS UNIVERSITY (US) 2008-08-26 US disclosed
US-20070275987-A1 Novel pyridopyprimidinone derivatives which are HM74A agonists HOFFMAN-LA ROCHE INC 2007-11-29 US disclosed
US-7273953-B2 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2007-09-25 US disclosed
US-20060069287-A1 Process for producing arylamine FUJIFILM FINECHEMICALS CO., LTD. (JP) 2006-03-30 US disclosed
US-20050019218-A1 Polymer based lanthanide luminescent sensors for the detection of organophosphorus compounds MURRAY GEORGE M (US) 2005-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069287-A1 Process for producing arylamine TYR, AADAC, AOC2 CES1 2515/4885CES2 393/4885TSHR 605/4885
US-20070275987-A1 Novel pyridopyprimidinone derivatives which are HM74A agonists GPR119, HCAR1, GPR84 CES1 749/4885CES2 3977/4885TSHR 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.